Journals / Güncel Retina Dergisi / 2018 / Cilt: 2 - Sayı: 1

Retinopathy of Prematurity: Clinical Diagnosis and Classification

Prematüre Retinopatisi’nde Klinik Tanı ve Sınıflandırma

Pages
21–28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review aims to give information about the clinical diagnosis and classification of ROP

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Retinopathy of prematurity (ROP) is an important and preventable cause of childhood blindness.
📊
Key Findings & Data:For this reason, in the VISION 2020 program initiated by the World Health Organization to eliminate avoidable blindness, the control of the disease was highlighted.
💡
Conclusion & Impact:This review aims to give information about the clinical diagnosis and classification of ROP
🔬Design:Review & Systematic Survey
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Abstract

Retinopathy of prematurity (ROP) is an important and preventable cause of childhood blindness. For this reason, in the VISION 2020 program initiated by the World Health Organization to eliminate avoidable blindness, the control of the disease was highlighted. As the survival rate of very low birth weight infants increases in developing countries, including our country, due to improvements in neonatal care, the frequency of the disease has increased. The basic strategy for the prevention of blindness from ROP is to identify the patients requiring treatment by examining them according to a certain protocol. In this process, also called “Screening program”, it is important to identify as many babies needing treatment as possible, while minimizing the number of examinations. In this respect, the risk group should be well- defined, and diagnosis, follow-up and treatment process should be done in line with a standard protocol. This review aims to give information about the clinical diagnosis and classification of ROP

Özet

Prematüre retinopatisi çocukluk çağı körlüklerinin önemli ve önlenebilir nedenlerinden birisidir. Bu açıdan Dünya Sağlık Örgütü tarafından önlenebilir körlüklerin engellenmesi amacıyla başlatılmış olan VISION 2020 programında hastalığın kontrolü öncelikli olarak vurgulanmıştır. Ülkemizin de yer aldığı gelişmekte olan ülkelerde, yenidoğan yoğun bakım koşullarındaki iyileşmelere bağlı olarak daha küçük bebeklerin yaşama şansı bulması, bu ülkelerde hastalık sıklığındaki artışı da beraberinde getirmektedir. Prematüre retinopatisi' ne bağlı körlüklerin önlenmesinde temel strateji, risk grubundaki bebeklerin standart bir çerçeve içinde muayene edilerek, tedavi gereken hastaların tespit edilmesidir. Tarama adı verilen bu süreçte amaç, tedavi ihtiyacı olabilecek en yüksek sayıda bebeğin, mümkün olan en az sayıda muayene ile belirlenebilmesidir. Bu açıdan, erken doğan bebeklerde risk grubunun iyi belirlenmesi, tanı, takip ve tedavi süreçlerinin belirli bir standart çerçeve içinde yapılması önem arz etmektedir. Bu derlemede prematüre retinopatisi 'nin klinik tanısı ve bu süreçte kullanılan sınıflandırmalar hakkında bilgi verilmesi amaçlanmıştır

🔖

Cite This Article

KARA, C., PETRİÇLİ, İ. S. (2018). Retinopathy of Prematurity: Clinical Diagnosis and Classification. Güncel Retina Dergisi, Cilt: 2 - Sayı: 1, 21–28. https://ajindex.com/articles/186425

References (16)

  1. Gilbert C, Foster A. Childhood blindness in the context of VISION 2020--the right to sight. Bull World Health Organ. 2001;79(3):227-232
  2. Campbell K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach. Med J Aust. Jul 14 1951;2(2):48-50
  3. Hatfield EM. Blindness in infants and young children. Sight Sav Rev. Summer 1972;42(2):69-89
  4. Gibson DL, Sheps SB, Schechter MT, Wiggins S, McCormick AQ. Retinopathy of prematurity: a new epidemic? Pediatrics. Apr 1989;83(4):486-492
  5. Gilbert C, Rahi J, Eckstein M, O’Sullivan J, Foster A. Retinopathy of prematurity in middle-income countries. Lancet. Jul 05 1997;350(9070):12-14
  6. Terry TL. Retrolental fibroplasia. J Pediatr. Dec 1946;29(6):770-773
  7. CLASSIFICATION of retrolental fibroplasia. Am J Ophthalmol. Oct 1953;36(10):1333-1335
  8. An international classification of retinopathy of prematurity. The Committee for the Classification of Retinopathy of Prematurity. Arch Ophthalmol. Aug 1984;102(8):1130-1134
  9. An international classification of retinopathy of prematurity. II. The classification of retinal detachment. The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity. Arch Ophthalmol. Jul 1987;105(7):906- 912
  10. International Committee for the Classification of Retinopathy of P. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. Jul 2005;123(7):991-999
  11. Shah PK, Narendran V, Kalpana N, Tawansy KA. Anatomical and visual outcome of stages 4 and 5 retinopathy of prematurity. Eye. 08/03/online 2007;23(1):176- 180
  12. Cusick M, Charles MK, Agron E, Sangiovanni JP, FERRIS III FL, Charles S. Anatomical and visual results of vitreoretinal surgery for stage 5 retinopathy of prematurity. Retina. 2006;26(7):729-735
  13. Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. Apr 1988;106(4):471-479
  14. Early Treatment For Retinopathy Of Prematurity Cooperative G. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. Dec 2003;121(12):1684-1694
  15. Sanghi G, Dogra MR, Dogra M, Katoch D, Gupta A. A hybrid form of retinopathy of prematurity. Br J Ophthalmol. Apr 2012;96(4):519-522
  16. Reynolds JD, Hardy RJ, Kennedy KA, Spencer R, van Heuven WA, Fielder AR. Lack of